Company News for May 26, 2009

• According to a New York Times report, Amgen (NASDAQ:AMGN - Analyst Report) plans to exercise its option to acquire rights to Cytokinetics' experimental heart drug

• Apple (NASDAQ:AAPL - Analyst Report) was upgraded by Morgan Stanley (NYSE:MS - Snapshot Report) to "overweight," as its analyst increased 2010 earnings estimate to $7.50 from $5.52, citing better-than-expected earnings from iPhone strength. The price target was raised to $180

• Natural Foods (NASDAQ:UNFI - Analyst Report) was downgraded by Goldman Sachs (NYSE:GS - Analyst Report) to "sell" from "neutral," on price considerations

• Freddie Mac (NYSE:FRE - Analyst Report) plans the first commercial bond deal in almost a year on Tuesday, with a $1 billion commercial mortgage bond sale back by multi-family loans

• Canadian Solar (NASDAQ:CSIQ - Analyst Report) reported a first quarter loss of 10 cents per share, topping estimates by 16 cents, as revenues plunged 71.1% year-over-year to $49.5 million

• Hewlett-Packard (NYSE:HPQ - Analyst Report) recalled 15,000 laptop batteries distributed in China

• Rio Tinto (NYSE:RTP - Analyst Report) announced agreement with Japan's Nippon Steel to cut contract prices for iron ore 33%